Goldman Sachs analyst Akinori Ueda initiated coverage of M3 Inc. with a Buy rating and 5,450 yen price target. Demand for the products and services offered by healthtech companies in Japan is transitioning to "stable expansion" after the pandemic fueled more rapid growth, said Ueda, who expects "solid" sales and operating profit growth from M3.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See the top stocks recommended by analysts >>
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue